Market Closed -
Nyse
16:00:01 2024-05-01 EDT
|
5-day change
|
1st Jan Change
|
338.9
USD
|
-0.94%
|
|
-7.77%
|
-6.21%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
8,508
|
12,612
|
18,576
|
19,285
|
21,064
|
19,858
|
-
|
-
|
Enterprise Value (EV)
1 |
5,365
|
8,710
|
13,109
|
13,956
|
14,137
|
16,685
|
15,061
|
13,670
|
P/E ratio
|
11.8
x
|
18.9
x
|
28.3
x
|
24.4
x
|
19.2
x
|
15.5
x
|
13.4
x
|
11.6
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
0.51
x
|
0.65
x
|
0.67
x
|
0.6
x
|
0.62
x
|
0.5
x
|
0.47
x
|
0.43
x
|
EV / Revenue
|
0.32
x
|
0.45
x
|
0.47
x
|
0.44
x
|
0.41
x
|
0.42
x
|
0.35
x
|
0.3
x
|
EV / EBITDA
|
4.67
x
|
6.55
x
|
10.5
x
|
8.69
x
|
8.07
x
|
8.06
x
|
6.48
x
|
5.32
x
|
EV / FCF
|
14.5
x
|
4.8
x
|
6.42
x
|
20.5
x
|
8.96
x
|
10.4
x
|
7.77
x
|
-
|
FCF Yield
|
6.9%
|
20.8%
|
15.6%
|
4.89%
|
11.2%
|
9.59%
|
12.9%
|
-
|
Price to Book
|
4.29
x
|
5.99
x
|
7.01
x
|
6.46
x
|
4.97
x
|
3.58
x
|
2.84
x
|
2.3
x
|
Nbr of stocks (in thousands)
|
62,700
|
59,300
|
58,400
|
58,400
|
58,300
|
58,600
|
-
|
-
|
Reference price
2 |
135.7
|
212.7
|
318.1
|
330.2
|
361.3
|
338.9
|
338.9
|
338.9
|
Announcement Date
|
20-02-10
|
21-02-10
|
22-02-09
|
23-02-08
|
24-02-07
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
16,829
|
19,423
|
27,771
|
31,974
|
34,072
|
39,652
|
42,523
|
46,162
|
EBITDA
1 |
1,148
|
1,330
|
1,244
|
1,606
|
1,751
|
2,070
|
2,324
|
2,572
|
EBIT
1 |
1,044
|
1,242
|
1,113
|
1,430
|
1,648
|
1,912
|
2,164
|
2,447
|
Operating Margin
|
6.2%
|
6.39%
|
4.01%
|
4.47%
|
4.84%
|
4.82%
|
5.09%
|
5.3%
|
Earnings before Tax (EBT)
1 |
972
|
961
|
875
|
1,063
|
1,464
|
1,706
|
1,979
|
2,259
|
Net income
1 |
737
|
673
|
659
|
792
|
1,091
|
1,273
|
1,465
|
1,692
|
Net margin
|
4.38%
|
3.46%
|
2.37%
|
2.48%
|
3.2%
|
3.21%
|
3.44%
|
3.66%
|
EPS
2 |
11.47
|
11.23
|
11.25
|
13.55
|
18.77
|
21.91
|
25.35
|
29.09
|
Free Cash Flow
1 |
370
|
1,816
|
2,042
|
682
|
1,578
|
1,600
|
1,939
|
-
|
FCF margin
|
2.2%
|
9.35%
|
7.35%
|
2.13%
|
4.63%
|
4.04%
|
4.56%
|
-
|
FCF Conversion (EBITDA)
|
32.23%
|
136.57%
|
164.15%
|
42.47%
|
90.12%
|
77.31%
|
83.44%
|
-
|
FCF Conversion (Net income)
|
50.2%
|
269.84%
|
309.86%
|
86.11%
|
144.64%
|
125.69%
|
132.39%
|
-
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
20-02-10
|
21-02-10
|
22-02-09
|
23-02-08
|
24-02-07
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
---|
Net sales
1 |
7,409
|
7,770
|
8,054
|
7,927
|
8,223
|
8,149
|
8,327
|
8,548
|
9,048
|
9,931
|
9,780
|
9,929
|
10,097
|
10,468
|
10,487
|
EBITDA
1 |
275
|
434
|
408
|
392
|
371
|
499
|
487
|
444
|
362
|
494
|
499.6
|
541.9
|
516.1
|
586.5
|
600.4
|
EBIT
1 |
240
|
394
|
367
|
347
|
324
|
455
|
445
|
402
|
346
|
449
|
458.9
|
502.8
|
480.8
|
547.9
|
562.1
|
Operating Margin
|
3.24%
|
5.07%
|
4.56%
|
4.38%
|
3.94%
|
5.58%
|
5.34%
|
4.7%
|
3.82%
|
4.52%
|
4.69%
|
5.06%
|
4.76%
|
5.23%
|
5.36%
|
Earnings before Tax (EBT)
1 |
136
|
344
|
334
|
307
|
78
|
427
|
416
|
332
|
289
|
399
|
408.1
|
449.6
|
429.6
|
497.3
|
493.8
|
Net income
1 |
103
|
258
|
248
|
230
|
56
|
321
|
309
|
245
|
216
|
301
|
309.8
|
336.1
|
314.3
|
375.5
|
372.2
|
Net margin
|
1.39%
|
3.32%
|
3.08%
|
2.9%
|
0.68%
|
3.94%
|
3.71%
|
2.87%
|
2.39%
|
3.03%
|
3.17%
|
3.38%
|
3.11%
|
3.59%
|
3.55%
|
EPS
2 |
1.740
|
4.390
|
4.250
|
3.950
|
0.9600
|
5.520
|
5.350
|
4.210
|
3.700
|
5.170
|
5.245
|
5.893
|
5.511
|
6.426
|
6.643
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
22-02-09
|
22-04-27
|
22-07-27
|
22-10-26
|
23-02-08
|
23-04-26
|
23-07-26
|
23-10-25
|
24-02-07
|
24-04-24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
3,143
|
3,902
|
5,467
|
5,329
|
6,927
|
3,173
|
4,796
|
6,187
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
370
|
1,816
|
2,042
|
682
|
1,578
|
1,600
|
1,939
|
-
|
ROE (net income / shareholders' equity)
|
40.9%
|
33.2%
|
27.9%
|
37.5%
|
30.4%
|
26.9%
|
24.5%
|
22.4%
|
ROA (Net income/ Total Assets)
|
10.6%
|
8.25%
|
6.06%
|
8.55%
|
8.02%
|
7.67%
|
8.26%
|
8.31%
|
Assets
1 |
6,971
|
8,159
|
10,871
|
9,266
|
13,603
|
16,601
|
17,727
|
20,361
|
Book Value Per Share
2 |
31.60
|
35.50
|
45.30
|
51.10
|
72.70
|
94.50
|
119.0
|
148.0
|
Cash Flow per Share
2 |
6.650
|
-
|
36.20
|
13.20
|
28.60
|
36.10
|
36.50
|
42.10
|
Capex
1 |
57
|
74
|
77
|
91
|
84
|
100
|
105
|
113
|
Capex / Sales
|
0.34%
|
0.38%
|
0.28%
|
0.28%
|
0.25%
|
0.25%
|
0.25%
|
0.24%
|
Announcement Date
|
20-02-10
|
21-02-10
|
22-02-09
|
23-02-08
|
24-02-07
|
-
|
-
|
-
|
Last Close Price
338.9
USD Average target price
404.3
USD Spread / Average Target +19.30% Consensus |
1st Jan change
|
Capi.
|
---|
| -6.21% | 20.05B | | +11.30% | 123B | | +19.28% | 101B | | -2.68% | 38.99B | | -31.37% | 36.4B | | -13.15% | 3.08B | | -39.37% | 982M | | -32.49% | 312M |
Other Managed Healthcare
|